Bedford man with rare life-threatening swelling condition takes part in major medical research
A man with a rare condition which means his throat, stomach and face suddenly swell up is taking part in major medical research.
Jack Cope, aged 30, from Bedford, has lived with Hereditary Angioedema (HAE) – a condition inherited from his mother – his entire life.
He’s experienced unpredictable, painful attacks since a young age which cause severe swelling all over his body, including in his throat, stomach and face.
And now Jack – who works as a joiner – is taking part in a trial of a new drug to see if it will improve his quality of life.


And he’s encouraging others to get involved in research through Be Part of Research – a free service which makes it easy to find and take part in vital health and care research across the UK.
Jack’s potentially life-threatening episodes have worsened over time and frequently lead to visits to A&E.
“Sometimes, I wake up in the morning and my face or throat are swollen and I’ll be on the floor being sick and just in agony,” said Jack, who is also mindful of the impact it has on his partner Chloe.
“Chloe basically becomes my carer. One night, I woke up and felt like my face and throat were swollen so I woke Chloe. She flicked on the light and her face just dropped because I was swollen so much.


“We were able to get to the hospital in time but if I hadn’t woken up I wouldn't be here.”
Although the A&E team at Bedford Hospital are able to treat severe episodes, Jack has tried all possible treatments to prevent attacks of HAE, but none have worked for him.
A possible ray of light came when he was invited to sign up for an international clinical trial for a new drug therapy at Addenbrooke’s Hospital in Cambridge. Their research team – led by Dr Padmalal Gurugama – is the global leader for recruiting volunteers to the trial.
“If this can help me and stop anyone else from having to go through what I have, it’s a no-brainer,” Jack said.
The trial required a gruelling six-month period without any medication to flush out his system, which Jack described as hell. Despite the intense and recurring swelling attacks, he stuck with it in the hope the new drug can improve his quality of life.
Jack added: “I can’t help but think about what my mum, grandma and others have had to go through. Years ago, when my grandma had an episode and her tongue swelled up ... she stopped breathing and her heart stopped beating. She was brought back with a defibrillator and spent time in intensive care on a ventilator.”
These medical trials are supported by the National Institute for Health and Care Research (NIHR) in the East of England – and Jack is one of 76,062 participants who have taken part in the last year alone.